Bittner, V., Szarek, M., Aylward, P. E., Bhatt, D. L., Diaz, R., Fras, Z., … Schwartz, G. (2018). Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial. In Atherosclerosis Supplements (Vol. 32, pp. 24–25). Elsevier BV. https://doi.org/10.1016/j.atherosclerosissup.2018.04.072

Bittner, Vera, Michael Szarek, Philip E. Aylward, Deepak L. Bhatt, Rafael Diaz, Zlatko Fras, Shaun Goodman, et al. “Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial.” In Atherosclerosis Supplements, 32:24–25. Elsevier BV, 2018. https://doi.org/10.1016/j.atherosclerosissup.2018.04.072.

Bittner V, Szarek M, Aylward PE, Bhatt DL, Diaz R, Fras Z, et al. Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial. In: Atherosclerosis Supplements. Elsevier BV; 2018. p. 24–5.

Bittner, Vera, et al. “Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial.” Atherosclerosis Supplements, vol. 32, Elsevier BV, 2018, pp. 24–25. Crossref, doi:10.1016/j.atherosclerosissup.2018.04.072.

Bittner V, Szarek M, Aylward PE, Bhatt DL, Diaz R, Fras Z, Goodman S, Hanotin C, Harrington R, Jukema JW, Loizeau V, Moriarty P, Moryusef A, Pordy R, Roe MT, Sinnaeve P, White HD, Zahger D, Zeiher A, Steg PG, Schwartz G. Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial. Atherosclerosis Supplements. Elsevier BV; 2018. p. 24–25.